1Iuorno MJ,Nestler JE.Insulin-lowering drugs in polycystic ovary syndrome[J].Obstet Gynecol Clin North Am,2001,28(1):153-64.
2Sabrina Gill,Ann E.Taylor,Kathryn A.Martin,Corrine K.Welt,Judith M.Adams and Janet E.Hall Specific Factors Predict the Response to Pulsatile Gonadotropin-Releasing Hormone Therapy in Polycystic Ovarian Syndrome[J].The Journal of Clinical Endocrinology & Metabolism,2001,86(6):2428-2436.
3Nugent D,Vandekerckhove P,Hughes E,Arnot M,Lilford R.Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome[J].Cochrane Database Syst Rev,2000,(4):CD000410.
4Cardone VS.GnRH antagonists for treatment of polycystic ovarian syndrome[J].Fertil Steril,2003,80 Suppl 1:S25-31;discussion S32-4.
5R.A.Lobo and E.Carmina The Importance of Diagnosing the Polycystic Ovary Syndrome Ann Intern Med[J].2000,132(12):989-993.
6Dunaif A,Thomas A.Current concepts in the polycystic ovary syndrome[J].Annu Rev Med,2001,52:401-19.
7Robert J Norman,Ruijin Wu and Marcin T Stankiewicz[J].Polycystic ovary syndrome MJA,2004,180(3):132-137.
8Ibanez L,Potau N,Ferrer A,et al.Anovulation in eumenorrheic,nonobese adolescent girls born small for gestational age:insulin sensitization induces ovulation,increases lean body mass,and reduces abdominal fat excess,dyslipidemia,and subclinical hyperandrogenism[J].J Clin Endocrinol Metab,2002,87:5702-5705.
9Enrico Carmina and Rogerio A.LoboPolycystic Ovary Syndrome(PCOS):Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women[J].The Journal of Clinical Endocrinology & Metabolism,1999,84(6):1897-1899.
10Pierpoint T,McKeigue PM,Isaacs AJ,et al.Mortality of women with polycystic ovary syndrome at long-term follow-up[J].J Clin Epidemiol,1998,51:581-586.
